Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-02

Clinical Trial Update: Safety and Efficacy of Umbilical Cord Blood Therapy for Cancer Therapy-Induced Thrombocytopenia (CTIT) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the safety and efficacy of Umbilical Cord Blood Therapy for cancer treatment-induced thrombocytopenia, and is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Umbilical Cord Blood Therapy

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Thrombocytopenia, Cancer Treatment-induced Thrombocytopenia | Phase 2 | Status: RECRUITING